Bortezomib triggers strong activation of mitochondria-dependent apoptosis in NSCLC cells accompanied by up-regulation of BH3-only protein NoxA and restores effective activation of caspase-9

Jens Voortman; Agnieszka Checinska; Giuseppe Giaccone; Frank A. E. Kruyt

Bortezomib triggers strong activation of mitochondria-dependent apoptosis in NSCLC cells accompanied by up-regulation of BH3-only protein NoxA and restores effective activation of caspase-9

Jens Voortman, Agnieszka Checinska, Giuseppe Giaccone, Frank A. E. Kruyt

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Journal	Cancer research
Volume	66
Issue number	8
Publication status	Published - Apr 2006

Cite this

@article{9f3f9a436ac34696bedfea9b6f36bfb0,

title = "Bortezomib triggers strong activation of mitochondria-dependent apoptosis in NSCLC cells accompanied by up-regulation of BH3-only protein NoxA and restores effective activation of caspase-9",

author = "Jens Voortman and Agnieszka Checinska and Giuseppe Giaccone and Kruyt, {Frank A. E.}",

year = "2006",

month = apr,

language = "English",

volume = "66",

journal = "Cancer research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

number = "8",

}

Bortezomib triggers strong activation of mitochondria-dependent apoptosis in NSCLC cells accompanied by up-regulation of BH3-only protein NoxA and restores effective activation of caspase-9. / Voortman, Jens; Checinska, Agnieszka; Giaccone, Giuseppe et al.
In: Cancer research, Vol. 66, No. 8, 04.2006.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - Bortezomib triggers strong activation of mitochondria-dependent apoptosis in NSCLC cells accompanied by up-regulation of BH3-only protein NoxA and restores effective activation of caspase-9

AU - Voortman, Jens

AU - Checinska, Agnieszka

AU - Giaccone, Giuseppe

AU - Kruyt, Frank A. E.

PY - 2006/4

Y1 - 2006/4

M3 - Meeting Abstract

SN - 0008-5472

VL - 66

JO - Cancer research

JF - Cancer research

IS - 8

ER -